Greater Glasgow and Clyde Medicines

Medicines Update

For all healthcare professionals across NHSGGC both in primary care and the acute sector.

Please note, Medicines Update blogs are correct at the time of publication.

Medicines Update blogs remain on the website for 4 years. If you would like a copy of a blog published more than 4 years ago, please contact  medicines.update@ggc.scot.nhs.uk.

Click here for a promotional poster on Medicines Update and here for an animation on the Communications subcommittee of ADTC resposnsible for the development of Medicines Update.

If you would like to contribute to Medicines Update, click here for a guide to blog writing and the checklist to complete prior to submitting a blog to the Communications Subcommittee of ADTC.

06/09/2023 announcement

Accessing GGC Clinical Guidelines via Medicines Update blogs and the Adult Therapeutics Handbook 

GGC Clinical Guidelines have migrated to the Right Decisions for Health and Care platform. As a result of the migration, direct links to GGC guidelines within Medicines Update blogs (and the Adult Therapeutics Handbook, GGC Medicines App) currently go to the homepage and not individual guidelines. This change was out with our control. 
Please note, there is a message on the homepage highlighting intermittent issues with the search function, therefore, if you cannot find a guideline via the search box, select the relevant category from the homepage or if the guideline still can't be found, contact clinical.guidelines@ggc.scot.nhs.uk
An update will be provided in due course.

Drug-Induced QTc Prolongation in Adults - Risk Factors

Posted: Friday, October 6, 2023

Category - Medicines Update

Drug-Induced QTc Prolongation in Adults - Risk Factors here

Key Messages

  • Causes of QTc prolongation may be either inherited or acquired
  • Drug induced QTc prolongation is the most common aetiology of acquired QTc prolongation
  • Risk factors for QTc prolongation may be modifiable or non-modifiable
  • Ensure that risk factors are reviewed and any modifiable risk factors such as electrolyte disturbance are corrected
  • The concurrent use of more than one drug which prolongs the QTc interval increases the risk of Torsades de Pointes (TdP) and ventricular arrhythmia
  • Some drugs which do not prolong the QTc interval themselves can increase the risk of QTc prolongation by affecting the metabolism of drugs which do
  • Some drugs can increase the risk of QTc prolongation by causing electrolyte disturbances (in particular hypokalaemia, hypomagnesaemia and more rarely hypocalaemia) especially when given with QTc prolonging drugs
  • Prescribers should ensure that the potential benefits of prescribing a QTc prolonging medication outweigh the associated risks, and that when a QTc prolonging medication is prescribed, appropriate mitigations and monitoring are in place
Read More...

Polypharmacy Review in Adults living with Moderate to Severe Frailty - Anticholinergic burden

Posted: Friday, October 6, 2023

Category - Medicines Update

Anticholinergic burden here

Key messages
  • Anticholinergic drugs are associated with an increased risk of falls, confusion, and are linked to increased mortality in the older population (aged 65 years and older) 
  • Adverse effects are cumulative and include constipation, urinary retention, postural hypotension, dizziness, and confusion 
  • Review anticholinergic medications regularly to ensure treatment is still effective and the benefit outweighs the risk of harm
Read More...

Key Medicine Shortages – October 2023

Posted: Wednesday, October 4, 2023

Category - Medicines Update

Key Medicine Shortages October 2023 here

Includes:

Medicines for the treatment of attention deficit hyperactivity disorder (ADHD), Estradiol valerate/medroxyprogesterone acetate (Indivina®) 1mg/5mg tablets, Lixisenatide (Lyxumia®) 20micrograms/0.2ml solution for injection, Hyoscine hydrobromide (Scopoderm®) 1.5mg patches, Midazolam (Epistatus®) 2.5mg/0.25ml and 10mg/1ml oromucosal solution pre-filled oral syringes and products used in the treatment of scabies.

Read More...

Myasthenia Gravis in Acute Care

Posted: Friday, September 29, 2023

Category - Medicines Update

Myasthenia Gravis in Acute Care here

  • Do not withhold, omit or delay doses of medicines for MG (e.g. pyridostigmine or
    steroids) as there is a risk of myasthenic crisis if not administered on time.
  • Where a patient does not have an individual supply of pyridostigmine this must be
    obtained urgently from pharmacy during working hours or via the local emergency
    cupboard, ward 67 at QEUH or the on call pharmacist if out of hours.
  • Contact on call neurology registrar as soon as possible after admission (including out
    of hours) for patients with a history of MG that are experiencing MG related issues.
  • Contact on call neurology routinely to inform them of admission for patients with a
    history of MG that are not experiencing any symptoms.
  • High risk situations for patients with MG include: nil by mouth (NBM) status, infection
    and surgical procedures
  • Some medicines can worsen or induce myasthenia gravis. Before prescribing any
    new medicines check the safety in the following guideline link
Read More...

Parkinson's Disease (PD) in Acute Care

Posted: Wednesday, September 13, 2023

Category - Medicines Update

Access to the correct medications at the right time can be a problem for patients with PD when they are admitted to hospital.

Ensure medicines reconciliation is undertaken within 24 hours of admission – include the following: drug name, formulation, strength, dose and frequency. Exact dose timing of PD medications should be clearly annotated on HEPMA.

Read More...

Drug-Induced QTc Prolongation - Interpretation of the QT Interval in Adults

Posted: Monday, September 11, 2023

Category - Medicines Update

Drug-Induced QTc Prolongation - Interpretation of the QT Interval in Adults here

  • Prolongation of the QT interval can lead to a life threatening arrhythmia known as Torsades de Pointes (TdP)
  • QT interval needs to be adjusted for heart rate, generating the widely used QTc (the corrected QT interval)
  • There are several calculations available to correct the QT interval, with Bazett being the most widely used formula and the one used by many ECG machines to calculate the automated QTc. Bazett is however associated with significant limitations, which should be taken into account when interpreting the QTc reported on ECG printouts
  • When reviewing a patients’ ECG, it is important not to look at the QTc interval in isolation to ensure that other conditions such as bradycardia, tachycardia, myocardial infarction or cardiomyopathy are not responsible for any changes in QTc
Read More...